Press Releases

2013-04-25

BIO: debating value in Chicago

 At the BIO International convention in Chicago, analysts have reported strong performance from the global biotech sector.They pointed out that there is an urgent need for the industry to demonstrate value of products under development. For 2012, Ernst & Young’s industry report “Beyond borders” reports an increase in revenues by 8% to US$ 89.8bn, with the net income of US$5.2 bn, representi...
2013-04-24

Horizon teams up with AstraZeneca

 AstraZeneca has exclusively licenced Horizon Discoverys kinase target programme.Horizon Discovery and AstraZeneca have entered into an exclusive collaboration and license agreement to explore Hori...
2013-04-10

Trial success for Lundbeck

 In a thorough comparison, Lundbecks new antidepressant Brintellix shone brightly: On a system for rating depression patients performed better.Danish H. Lundbeck A/S reported on positive results fo...
2013-04-08

AstraZeneca fails endpoint

 AstraZenecas arthritis pill fostamatinib is proven inferior to competitor drugs in a late-stage clinical trial.While the first-in-class oral rheumatoid (RA) arthritis drug proved to be efficient a...
2013-04-05

Clavis 2nd lead failed

 Clavis Pharma has become a target for a take-over after its cancer drug delivery technology failed proof-of-concept for the second time.In November, US partner Clovis Oncology said it will termina...
2013-03-14

British Shire plc has broadened its therapeutic scope to neonatology by the strategic acquisition of Swedish Premacure AB of Uppsala.

The privately held biotech company is running a dose finding, safety and efficacy Phase II programme for the most common cause of visual loss in childhood – the prevention of retinopathy of prematu...
2013-03-08

Active Biotech raises €32.4m

 SwedishActive Biotech has issued new shares to obtain money for its clinicalautoimmunity and cancer programmes. 0 false 21 18 pt 18 pt 0 0 false false false ...
2013-02-15

The latest breakthroughs in adaptive designs to be disclosed

Clinical trials run by pharmaceutical and biotech companies have undergone major changes, implementing adaptive designs to tailor a trial. Reduction in costs and timings of early phase ...
2013-02-12

Biofuels producers join forces

 Seven leading producers of second generation biofuels have joined forces in anindustry initiative to support uptake of their technology.The initiative,named “Leaders of Sustainable Biofuels”, aims...
2013-02-11

FDA rejects Novo’s Tresiba

0 false 21 18 pt 18 pt 0 0 false false false /* Style Definitions */table.MsoNormalTable {mso-style-name:"Normal tabell"; mso-tstyle-rowband-size:0; mso-tst...
2013-02-09

EU approves Sanofi’s Lyxumia

 The EuropeanCommission has granted EU market authorisation to Sanofi’s GLP-1 receptoragonist licisenatide as a diabetes therapy. 0 false 21 18 pt 18 pt 0 0 false false false ...
2013-02-01

New cancer collaborations

 Swiss4-Antibody and Ludwig Institute will expand their cooperation, whileCurie-Cancer and Genosplice Technology inked a cancer genomics pact. 0 false 21 18 pt 18 pt 0 0 false f...
2013-01-11

GeneReach- from samples to results, your one-stop solution for mulecular diagnostics is looking for distributors

 GeneReach Biotechnology Corporation (GeneReach), founded in 1993, is a supplier of viral and genetic diagnosis products. Since 1995, we have focused our R&D on viral diagnosis associated with ...
2013-01-07

ETHRIS ANNOUNCES RESEARCH BASED ALLIANCE ON SNIM® MODIFIED RNA WITH SHIRE

  ethris GmbH and Shire today announce the initiation of a research based alliance focused on the development and commercialization of novel RNA-based therapeutics.Many devastating human diseases a...
2013-01-06

Promising year for TB patients

 The new year could be particularly beneficial for tuberculosis patients. Two new drugs are expected to be approved by the EMA.After almost 50 years without new treatments against tuberculosis, 201...
2013-01-04

Wellcome Trust invests a £200m VC

 The Wellcome Trust’s new venture capital unit Syncona Partners LLC pours £200m into early stage healthcare start ups.The world’s second largest charity plans to invest between £1m-£20m in each of ...
2012-12-21

Spanish researchers have unraveled how HIV disperses throughout the body – and can block the process before it occurs.

 In a previous publication with Swiss and German virologists, researchers headed by Nuria Izquierdo-Useros from the AIDS Research Institute IrsiCaixa in Barcelona discovered that the HI virus uses ...
2012-12-18

First FDA approval without trials

GSK’s monoclonal antibody against anthrax is the first to get FDA approval without having been tested for efficacy in humans. This antibody is a very special one: fast track designation, priority ...
2012-12-11

New cancer target draws €259m

 British pharma GlaxoSmithKline fosters its transatlantic ties. Texas-based MD Anderson will receive €259m for a cancer immune therapy programme. GlaxoSmithKline (GSK) secured a promising can...
2012-12-05

Baxter International Inc. strengthens its dialysis business with the acquisition of Swedish Gambro AB.

Private equity investors sold the firm for about US-$4bn. Gambro has a product portfolio in global home dialysis. The acquisition positions Baxter as the worldwide number two in the dialy...
2012-11-30

Nestlé forms Joint Venture

 Nestlé Health Science SA and Chi-Med have agreed to form a 50/50 joint venture, to be named Nutrition Science Partners Limited. The Swiss entity and the subsidiary of Hutchinson Whampoa Ltd....
2012-11-17

New US contracts cool conflict

Despite an ongoing dispute, the US government has signed two new contracts with Danish vaccine developer Bavarian Nordic. The Danish drugmaker announced the closing of two new contracts with the U...
2012-11-09

Pharming: US approval in sight

Dutch Pharming and its US-partner Santaris Inc. have reported positive Phase III results for Ruconest, their treatment of hereditary angioedema. The development of Pharmings C1 inhibitor Rhucin, a...
2012-11-07

Second Round of funding

The British government-backed Biomedical Catalyst has started its second round of funding. A total of £39m will be given to 32 of UK’s leading life science projects. The money comes from a £180m f...
2012-10-29

Menarini catches ADC fever

 Italian Menarini Group and Oxford Biotherapeutics want to jointly develop five antibody-based drugs. The deal is worth €800m.„I am very pleased to announce this novel strategic alliance, whichfore...
2012-10-17

The European Commission gives €6m to a research consortium tackling a severe immune system disorder. „FIGHT HLH“ is led by Swiss Novimmune.

 The European Commission wants to dismantle a malicious disease. By spending €6m of FP7 money for research into hemophagocytic lymphohistiocytosis (HLH), it wants to advance knowledge about possibl...
2012-10-13

Novasep builds €30m plant

 French chromatography specialist Novasep will create the worlds largest chromatography plant for the pharmaceutical industry.French bio-chromatography provider Novasep S.A. is set to build the wor...
2012-10-11

A kidney relief drug worth €673m

 British-Swedish Astra Zeneca pays Californian start-up Ardelyx up to €673m to get hold on exclusive rights for their NHE3 inhibitor programme.After a setback this summer with an anti-obesity drug,...
2012-10-08

The Nobel Prize in Physiology or Medicine 2012

 The Nobel Prize recognizes two scientists who discovered that mature, specialised cells can be reprogrammed to become immature cells capable of developing into all tissues of the body. Their findi...
2012-10-03

EMA changes biosimilar rules

 The European Medicines Association has changed its biosimilars guidelines to make it easier to develop biologic follow-on drugs in both the US and Europe.The London-based agency said it intends to...
2012-10-02

Sobi and Biogen success in Phase III

 Swedish Sobi and Biogen Idec have proved safety and efficacy of a haemophila B drug that prevents bleeding three times longer than other clotting factors.In the B-LONG Phase III study on 126 haemo...
2012-09-21

Baltic biotech attracts investors

  The very first Life Science Baltics 2012 attracted twice as many visitors than anticipated. Investors are lured by EU funds, low cost and qualified staff.The very first Life Science Baltics confe...
2012-09-18

Astra Zeneca ends AZD2820 study

 Swedish-British pharma Astra Zeneca has stopped the development of one obesity drug but promises to back partner Palatin with the other candidates.US company Palatin Technologies, Inc. (Cranbury) ...
2012-09-17

Sweden boosts life sciences

  The Swedish Government is set to boost its life sciences industry with a US$320m investment over the next four years.Swedish Prime Minister Fredrik Reinfeldt confirmed the country’s largest ever ...
2012-09-01

Janssen enters deal with Genmab

In a deal worth up to US$1.1bn Janssen Biotech Inc has licensed the human monoclonal antibody daratumumab from Danish Genmab A/S. Janssen will pay US$55m up front to gain an exclusive worldwide li...
2012-09-01

CXCR2 blockers stop cancer

Formation of tumours can be significantly reduced by inhibition of a receptor that drives inflammation, according to a British-German research team. According to the scientists headed by Robert Ni...
2012-08-24

Symphogen meets Phase II endpoints

Danish Symphogen has published positive study results with the first recombinant polyclonal antibody therapy ever tested in clinical trials. Results of an open-label, dose-escalation Phase II stud...
2012-08-06

Doping for UKs biomedicine

 The UK government has pledged to invest additional €49m (£39m) in the countrys life science research.The Biomedical Catalyst Fund commited €12,6m (£10m) to 14 universities and 18 small- and medium...
2012-08-05

Cancer stem cells caught

 Belgian and UK researchers have for the first time tracked the existence of cancer stem cells in vivo. The study provides another piece of evidence that cancer stem cells are drivers of tumour rec...
2012-08-03

Europe reaches agreement on unitary patent

 On June 29th an agreement was reached at the European Council on the final outstanding issue in the negotiations on unitary patent protection, that is, where the seat of the Central Division of th...
2012-07-17

Antibody deal with Janssen

When it comes to bispecific antibodies Genmab’s Duobody technology is becoming more and more popular, with Janssen Biotech now also reliant on it. Danish Genmab A/S received an upfront payment of ...
2012-07-16

Bayer sells Trasylol business

German pharmaceutical and chemical company Bayer sells the business with controversially debated drug Trasylol. The privately-held Dutch pharma The Nordic Group receives the worldwide marketing rig...
2012-07-02

Vitrolife in IVF technology deal

Cell cultivation company Vitrolife announced it will acquire Hungarian Cryo Management Ltd, a specialist in time-lapse embryo monitoring for IVF. Gothenburg – The purchase sum is €5m, and could be...
2012-06-29

New biomarker for Alzheimer onset

GE Healthcare and the VTT Technical Research Centre have joint forces on validating a biomarker signature in a large patient cohort. Espoo/Chalfont St Giles/Beerse – Last December, researchers fro...
2012-06-17

Novozymes supplies Chinese pioneer

 The Danish world market leader in enzyme technology, Novozymes A/S, will supply a large scale bioethanol production plant in China.Baegsvaard – The deal was agreed during a visit from Hu Jintao, P...
2012-06-16

Nuevolution gets €11m to expand

 The Danish small molecule lead discovery SME has raised enough money for international expansion, with planned operations in Sweden. Copenhagen – In the past Nuevolution A/S from Copenhagen planne...
2012-06-15

Upsher-Smith to take over Proximagen

 US pharma firm Upsher-Smith Laboratories makes a bid to acquire UK-based drug developer ProximagenLondon/Cambridge/ Maple Grove – Upsher-Smith’s $553m bid to bagProximagen Group plc will add two p...
2012-06-01

Treating the cause

 A positive recommendation by EMAs CHMP committee raises hope for patients with cystic fibrosis in Europe.The EU agency recommended Kalydeco (ivacaftor) from the US-biotech Vertex for approval. The...
2012-05-30

Boosting regenerative medicine

 Regenerative medicine centres foster their translational approach. An international initiative formed in Germany, a new centre is opened in Scotland.Edinburgh/Enschede/Seville/Berlin/Toronto – The...
2012-05-29

UK endows £250m to life sciences

 With the aim to maintain its status one of the global leading life sciences nations, the UK has set up a large funding initiative.London – Minister for Universities and Science, David Willetts, an...
2012-05-25

$2.2bn: Agilent acquires Dako

 Agilent has paid US$2.2bn for diagnostics specialist Dako in the largest acquisition in its history.Glostrup/Santa Clara-based - It is the next billion dollar deal in the field of molecular diagno...
2012-05-03

Abbott Laboratories (ABT) Buys AP214 Hormone From Action Pharma for $110 Million

 Abbott (NYSE: ABT) and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.AP214 is in deve...
2012-04-23

AstraZeneca to Acquire Ardea Biosciences for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout

 AstraZeneca and Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced that they have entered into a definitive merger agreement, pursuant to which AstraZeneca will acquire Ardea, a San Diego...
2012-04-20

News on the European Cleanroom market

 The specialized cleanroom service company decontam GmbH based in Bad Windsheim near Nürnberghas has, from the 2ndof April 2012, become a part of Berendsen. decontam employs 40people and has b...
2012-04-17

A £180m fund designed to bridge the ‘valley of death’ for medical breakthroughs in the UK will kick off at the end of April

A £180m government scheme designed to support collaboration between innovative SMEs and academics for developing solutions to healthcare challenges will open for applications at the end of April, a...
2012-04-16

Sweden bolsters biotech

 Swedish pharma company Astra Zeneca plus Wallenberg Foundation and Swedish government pledge a record investment into the biotech industry.Stockholm – Under a new initiative, AstraZeneca will...
2012-04-13

Nordic States foster Bioeconomy

 Finland is the last Nordic country which has not yet decided to start a nationwide bioeconomy programme. Calls for such an strategy are becoming louder.Denmark has already implemented a natio...
2012-04-04

AstraZeneca is looking to partner with peers

 After signing a broad licensing deal with Amgen Inc. that involves five experimental compounds, AstraZeneca is looking for partnerships with industry peers. Martin Mackay, head of research at...
2012-03-28

BioChina International 2012-Biopharma and Bioprocessing Congress June 26 and 27 Shanghai, China

 On the way to achieve antibody industrialization, China is faced with challenges in transforming good research into effective products that can be reproduced in large quantities and meet all ...
2012-03-27

A new shortcut for stem cell programming

 Researchers at the University of Bonn artificially derive brain stem cells directly from the connective tissue of miceThese stem cells can reproduce and be converted into various types of bra...
2012-03-26

IMMUNE CELLS WITH A KILLER INSTINCT: TRIED-AND-TESTED ANTI-TUMOUR DRUG DISPLAYS NEW EFFECT

 Imiquimod, a drug used to treat skin cancer, has been shown to have a previously unknown effect on immune cells. The drug transforms cells known as dendritic cells into "tumour killers" that ...
2012-03-26

Roche runs for EU application of subcutaneous Herceptin

 Following promising results from a Phase III study, Roche has submitted a regulatory application to EMA for subcutaneous Herceptin (trastuzumab) to treat HER2-positive breast cancer. Roche sa...
2012-03-16

Eating meat makes you resistant to antibiotics

 Foodborne bacteria such as Salmonella and Campylobacter are becoming more and more resistant to antimicrobial drugs, according to a joint report published by the European food watchdog EFSA a...
2012-03-15

Norway is pushing forward personalised cancer treatments in its national health care system

With a bold approach, including next-generation DNA sequencing (NGS) and state-of-the-art biobanking systems, Norway is pushing forward personalised cancer treatments in its national health care sy...
2012-03-09

Enteric microbes affect blood vessel architecture

 Researchers at the Sahlgrenska Academy have discovered a previously unknown mechanism which helps intestinal bacteria to affect the formation of blood vessels. In a study of mice, the team le...
2012-03-06

No relief for alcoholics yet after Lundbeck Phase III results

 Danish pharmaceutical company H. Lundbeck A/S yesterday unveiled clinical data on its potential blockbuster drug nalmefene at the 2012 European Congress of Psychiatry clinical in Prague. Whil...
2012-03-02

EC launches Innovation partnerships to foster sustainable research

 Brussels – With three new Innovation Partnerships, the European Commission (EC) intends to eliminate weaknesses, bottlenecks and obstacles in the European research and innovation system....
2012-03-01

Big science teams up with big business to kick-start European cloud computing

 Geneva, 1 March 2012. Today a consortium of leading IT providers and three of Europe’s biggest research centres (CERN, EMBL and ESA) announced a partnership to launch a European clo...
2012-03-01

Middle East Expansion for IKS International

 Following successful discussions at Arab Health 2012, IKS International (Rosmalen, the Netherlands) has secured its first major contract in the UAE, to supply a XiltriX® laboratory monitoring...
2012-02-28

$300m deal to fight a rare disease

 London/Montreal - Angiochem will collaborate with British pharma trust GlaxoSmithKline (GSK) plc on treatments for lysosomal storage diseases (LSD). London-based GSK will pay $300m, including...
2012-02-27

Delcath Announces First CHEMOSAT Procedures in Germany

 Johann Wolfgang Goethe University Hospital Becomes Second Training Center in Europe to Treat Patients with Delcath Hepatic CHEMOSAT® Delivery SystemNEW YORK, Feb. 27, 2012 /PRNewswire/ -- Del...
2012-02-24

The Pharma Outsourcing and Procurement Summit 2012 Programme Is Now Live!

 This year’s Pharma Outsourcing and Procurement Summit will take place on the 21st – 22nd May 2012 at the Hotel Palace Berlin, Germany. This summit will bring together over 100+ senior le...
2012-02-23

Probiotic strain reduces diarrhoea in kids

 Stockholm - Probiotics can help prevent diseases, Swedish researchers have found out. The results are in sharp contrast with all health claim judgements involving probiotics published by the ...
2012-02-23

EMA pushes its transparency initiative forward

 London – The European Medicines Agency (EMA) will publish information about all drugs under review, beginning on March 1. On a monthly basis the company will issue a list disclosing...
2012-02-21

International Oncology Conference

 Oncology is one of the fast progressing fields in medicine. Oncologists world over are finding cure for cancer. Fleming Gulf  Conferences has taken an initiative to bring all the oncolog...
2012-02-20

An ocean of fuels

 Copenhagen/Bangalore – Biofuels need reliable sources of biomass. Novozymes now looks to the ocean to secure biomass. The Danish enzyme specialist announced an exploratory research agree...
2012-02-17

Clavis Pharma gets €21m for anti-cancer pipeline

 Oslo – The north lights up with financial flares. Norwegian cancer specialist Clavis Pharma ASA has raised €21m through a placement of new shares. The 2.8 million shares represent approximate...
2011-09-14

Uppsala BIO signs first European open innovation agreement with Roche for its program BIO-X

 Swedish life science initiative Uppsala BIO has formed a strategic partnering  agreement with Roche, the world leading pharmaceuticals and diagnostics company, for Uppsala BIO’s open inn...
2011-08-25

Global proteomics researchers gather to advance the Human Proteome Project at HUPO 2011

 Leading proteomics researchers are gathering at the HUPO 2011 meeting in Geneva, Switzerland, to define new short-term milestones for the Human Proteome Project (HPP). This global collaborati...
2011-08-19

MipTec 2011: Newest discoveries and innovations to be presented at the international life sciences meeting point in Basel

 From 20 – 22 September 2011, Basel will turn again into the international meeting point in the field of Life Sciences. The MipTec Drug Discovery Conference will take place for the first time ...
2011-08-15

Stanford researchers separate tumor-causing stem cells from therapeutic one

 A major obstacle to widespread therapeutic use of human embryonic stem cells in therapy is this nasty tendency for a few of them to turn "Frankenstein" on us. Out of the tens of millions of p...
2011-06-15

 Mendor collaboration with Novartis Finland

 Finnish growth company Mendor starts collaboration with a global pharma corporation to develop diabetes treatmentMedical device growth company Mendor has started a local collaboration in Finl...
2011-06-14

Swedish technology producing major efficiencies, cost savings for Canadian hospitals, states Swedens ambassador to Canada

 TORONTO, June 14, 2011 /CNW/ - Swedish technology is playing a major role in helping Canadian hospitals operate more efficiently and realize significant cost savings, said Teppo Tauriainen, S...
2011-06-01

Stem cell technology used in unique surgery in Gothenburg

 Prof. Michael Olausson, responsible for the unique surgery at Sahlgrenska University Hospital.Photo: Björn Larsson RosvallFor the first time ever in the world, researchers at the Sahlgrenska ...
2011-06-01

Washington DC breakfast offers insights on designing your regulatory strategy

 These days, getting a dialogue started with regulators at a very early stage of development is one of the most important tasks for any biotech company. Their feedback on trial design, special...
2011-05-31

Clavis Pharma receives government grant to develop hENT1 biomarker assay for targeted therapy of AML patients

 Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, is pleased to announce that it has been awarded a grant from The Research Council of Norway of up to NOK 14 mil...
2011-05-31

Separating ELA from the Crowd

 Inaugural Advances in Separation Technology Conference to Join Streams at ELASelect Biosciences, organisers of European Lab Automation (ELA) 2011, today announced that the inaugural Advances ...
2011-05-31

How can genetic research help beat stomach cancer?

 STOMACH cancer affects about 530 Victorians each year, more commonly people aged over 50. Now a team of Monash Institute of Medical Research scientists has zeroed in on a gene that may contri...
2011-04-06

Bibby Scientific looks to the East with sales office in Singapore

 Bibby Scientific’s newest sales office is located in Singapore, opening up opportunities to build closer relationships with customers and dealers in the whole Asian region, including China, S...
2011-03-31

New Osteoporosis Assay From Astra Biotech Gmbh

 Osteoporosis affects over 75 million people worldwide and in a single year there are more than 9 million instances of osteoporotic fractures making it the fourth most significant non-infectio...
2011-03-09

Navigators Expands Swedish Underwriting Agency, NUAL AB

 NEW YORK, March 1, 2011—The Navigators Group, Inc. (NASDAQ:NAVG) today announced that its Swedish underwriting agency, NUAL AB, will now be offering Life Sciences insurance solutions. Magnus ...
2011-02-02

Fast Eight-Channel Nucleic Acid Analysis

 The world`s first true eight-channel, micro-volume spectrophotometer for measuring DNA,RNA and Proteins will be launched at the Pittcon exhibition in March.AstraNet Systems Ltd...
2010-10-28

A change of culture for healthcare

 A new committee of healthcare specialists believes that culture change within the industry must be targeted in one of two ways: either their first objective is to ‘do what you do better’ or l...
2010-10-13

Vitrolife expands its IVF product portfolio through acquisition in the USA.

Vitrolife is acquiring the business in Conception Technologies, USA. This means that Vitrolife will broaden their IVF product portfolio, increase cost-efficient production capacity and increase its...
2010-10-08

Genzyme Board Unanimously Rejects Sanofi-Aventis Tender Offer

 Genzyme announced today that its board of directors has voted unanimously to reject the unsolicited $69.00 per share tender offer from Sanofi-Aventis, and the board recommends that Genzyme sh...
2010-10-07

Fisher Scientific launches new e-catalogue for all Swedish laboratories.

 LABORATORY EQUIPMENT: The new e-catalogue is readily accessible on the Internet in a user-friendly format. It is easy to turn pages using the mouse and the catalogue offers a product overview...
2010-10-05

Major investment in women’s health UP TO $330M CAD INTERNATIONAL PARTNERSHIP BETWEEN BAYER HEALTHCARE PHARMACEUTICALS AND ENDOCEUTICS INC.

  Bayer HealthCare Pharmaceuticals (Bayer) and EndoCeutics Inc., Québec, are proud to announce the signing of an exclusive international collaborative agreement for Phase III development ...
2010-10-05

Biospain 2010: Spanish biotech industry looks for a global path

 Biotechnology has emerged in Spain as a key force driving economic change, estimated to contribute as much as 1.6 percent to the total GDP; with a total workforce of 100,000 highly qualified ...
2010-10-04

Pharmatest signes a master service agreement with bayer Schering Pharma AG

Pharmatest Services Ltd, a Finnish CRO specializing in non-clinical pharmalogical research services has signed a Master Service Agreement with bayer Schering Pharma AG, Germany.Pharmatest provides ...
2010-10-01

New outcomes study for ticagrelor (BRILINTA) to examine longer-term treatment for post- ACS patients

 AstraZeneca today announced the initiation of a large, international, clinical outcomes study for the investigational oral antiplatelet, ticagrelor (BRILINTATM/BRILIQUETM) in collaboration wi...
2010-09-30

AstraZeneca pays Riegel 25 million USD for arthritis drug`s milestones

 Rigel Pharmaceuticals earned $25 million from British drugmaker AstraZeneca after reaching two development milestones for a rheumatoid arthritis treatment.Rigel said Wednesday it reached one ...
2010-09-29

Early prostate test study gives hope for accuracy

 British scientists say they have developed a lab test that can accurately distinguish prostate cancer from healthy tissue and other prostate conditions -- a finding that may in future help me...
2010-09-29

Novo leads $31M round for Tobiras game-changing HIV program

 Novo A/S has stepped up to lead a $31 million Series B for Tobira Therapeutics, a New Jersey-based biotech that is pushing a next-gen HIV antiviral compound into a Phase IIb trial.Tobiras lea...
2010-09-28

Biotechnology poised to be Taiwan´s next high-tech success story

 Taiwan has achieved remarkable economic success, having transformed itself in a few short decades to the technology-driven economic powerhouse that it is today.Over the past 20 years Taiwan h...
2010-09-15

EFIB 2010 turns Edinburgh into the city of industrial biotechnology for a week

 EFIB 2010 turns Edinburgh into the city of industrial biotechnology for a weekThis years EFIB conference offers unrivalled networking opportunities with the exhibition being almost sold out, ...
2010-09-14

The Aminoff Prize 2011: Biological minerals inspires for the future

 The Royal Swedish Academy of Sciences has awarded The Gregori Aminoff Prize in crystallography 2011 to Professor Lia Addadi and Professor Stephen Weiner, both at the Weizmann Institute of Sci...
2010-09-08

ECCP 2010 - The Oncology Partnering Event in Europe for Biotechs, Pharma, Investors, and Academia

 The Oslo Cancer Cluster (Oslo, Norway) and the Cancer - Bio - Santé Cluster (Toulouse, France) welcome key players from the international oncology community to Oslo, Norway.ECCP2010 is a meet...
2010-09-07

Roche and reMYND enter into a strategic alliance to develop first-in-class disease-modifying treatments for Parkinson’s and Alzheimer’s disease

 Roche  and reMYND today announced that they have entered into an agreement to develop novel therapeutics that could slow down neurodegeneration in Parkinson’s and Alzheimer’s patients by...
2010-09-03

Scientists discover protein that fuels Alzheimers disease

 Researchers at Fisher Center for Alzheimers Disease Research Laboratory, US, have published "Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimers Disease" in Nature onlin...
2010-09-03

Meda will acquire Alaven Pharmaceutical

 Meda has signed an agreement to acquire the US specialty pharmaceutical company Alaven that develop and market prescription and non-prescription products that treat women`s health, gastroente...
2010-09-03

Nexus Becomes Pioneering International Member of Prestigious Scandinavian Cancer Organisation

 Nexus Oncology has announced it has joined the Oslo Cancer Cluster (OCC). Nexus becomes the first non-Scandinavian company to join the OCC, a non-profit member organisation that seeks to acce...
2010-09-02

Sigma Life Science launches range of engineered cell lines exploiting CompoZr® zinc finger nuclease technology

SigmaLife Science, the innovative biological products and research services business of Sigma-Aldrich® Corporation (Nasdaq:SIAL), today announced the global release of a pioneering range of enginee...
2010-08-24

Gyros AB launches new corporate website

24 August 2010, Uppsala, Sweden: Gyros AB has launched a new website to support its position as the leader in utilization of microfluidic technologies to miniaturize and automate immunoassays. The...
2010-08-20

Dr. Reddys chooses to implement Werums MES

Lueneburg, Germany, August 20, 2010 – Indian pharmaceutical major Dr. Reddys Laboratories Ltd. has decided to introduce PAS-X, the Manufacturing Execution System (MES) by Werum Software & Syste...
2010-08-19

Clinical benefits of radioactive microspheres

Multi-centre Phase II Trial reports safety and clinical benefits of radioactive microspheres in patients with colorectal cancer liver metastases who have failed chemotherapy. Rome – 19 August 2010...
1900-01-01

 Oncology is one of the fast progressing fields in medicine. Oncologists world over are finding cure for cancer. Fleming Gulf  Conferences has taken an initiative to bring all the oncolog...
1900-01-01

The Pharma Outsourcing and Procurement Summit 2012 Programme Is Now Live!

 This year’s Pharma Outsourcing and Procurement Summit will take place on the 21st – 22nd May 2012 at the Hotel Palace Berlin, Germany. This summit will bring together over 100+ senior le...
1900-01-01

The latest breakthroughs in adaptive designs to be disclosed

Clinical trials run by pharmaceutical and biotech companies have undergone major changes, implementing adaptive designs to tailor a trial. Reduction in costs and timings of early phase ...